HK Stock MarketDetailed Quotes

01618 MCC

Watchlist
  • 1.210
  • -0.030-2.42%
Market Closed Sep 10 16:08 CST
25.08BMarket Cap4.09P/E (TTM)

MCC Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Turnover
-10.65%298.84B
3.81%149.95B
6.95%633.87B
17.70%467.32B
15.65%334.46B
22.39%144.45B
18.40%592.67B
13.61%397.04B
15.22%289.2B
25.00%118.03B
Operating income
-10.65%298.84B
3.81%149.95B
6.95%633.87B
17.70%467.32B
15.65%334.46B
22.39%144.45B
18.40%592.67B
13.61%397.04B
15.22%289.2B
25.00%118.03B
Operating expenses
10.44%-271.8B
-5.25%-137.67B
-6.90%-572.46B
-18.21%-424.22B
-15.74%-303.47B
-23.84%-130.81B
-19.69%-535.52B
-14.04%-358.87B
-15.73%-262.19B
-26.32%-105.63B
Gross profit
-12.74%27.04B
-10.04%12.27B
7.46%61.41B
12.92%43.11B
14.72%30.99B
10.05%13.64B
7.56%57.15B
9.66%38.18B
10.49%27.01B
14.78%12.4B
Selling expenses
0.43%-1.39B
-6.35%-699.61M
-9.93%-3.17B
-14.71%-2.01B
-13.42%-1.39B
-10.80%-657.85M
-5.12%-2.88B
-0.16%-1.76B
-6.19%-1.23B
-8.42%-593.74M
Administrative expenses
-5.21%-5.71B
-3.76%-3.19B
-9.64%-12.36B
-10.94%-8.08B
-9.83%-5.43B
-10.56%-3.07B
-3.22%-11.27B
-0.40%-7.29B
2.02%-4.94B
-1.64%-2.78B
Research and development expenses
11.25%-8.07B
-0.11%-2.82B
-5.33%-19.73B
-15.76%-13.54B
-18.99%-9.09B
-7.14%-2.81B
-17.81%-18.73B
-17.88%-11.69B
-27.13%-7.64B
-54.55%-2.63B
Profit from asset sales
2,395.55%847.46M
832.47%147.71M
118.58%663.08M
-77.69%51.26M
-67.28%33.96M
117.27%15.84M
-55.99%303.36M
-47.48%229.74M
-75.74%103.78M
-10.24%7.29M
Revaluation surplus
34.04%-216.6M
-5,553.63%-183.86M
1.12%-314.22M
-10.35%-458.64M
-151.26%-328.38M
-140.28%-3.25M
-278.59%-317.78M
-604.71%-415.61M
-353.88%-130.7M
-25.85%8.07M
-Changes in the fair value of other assets
34.04%-216.6M
-5,553.63%-183.86M
1.12%-314.22M
-10.35%-458.64M
-151.26%-328.38M
-140.28%-3.25M
-278.59%-317.78M
-604.71%-415.61M
-353.88%-130.7M
-25.85%8.07M
Impairment and provision
-57.88%-4.87B
-0.46%-915.76M
-80.37%-8.95B
-0.78%-4.01B
-5.58%-3.08B
-7.47%-911.58M
7.07%-4.96B
-25.11%-3.98B
-38.32%-2.92B
-22.29%-848.22M
-Other impairment is provision
-57.88%-4.87B
-0.46%-915.76M
-80.37%-8.95B
-0.78%-4.01B
-5.58%-3.08B
-7.47%-911.58M
7.07%-4.96B
-25.11%-3.98B
-38.32%-2.92B
-22.29%-848.22M
Special items of operating profit
30.58%-351.75M
37.38%-150.35M
14.93%-927.25M
44.19%-512.87M
19.45%-506.66M
-85.71%-240.12M
20.17%-1.09B
-673.91%-919.01M
-18.17%-628.99M
-38.01%-129.3M
Operating profit
-37.45%6.38B
-25.39%4.1B
-9.93%14.7B
21.42%13.17B
17.01%10.2B
8.29%5.49B
7.28%16.33B
-7.00%10.85B
-2.56%8.72B
15.90%5.07B
Financing cost
-156.36%-637.3M
-16.02%-222.82M
-5.13%-989.12M
-1,280.18%-516.54M
-127.33%-248.6M
36.71%-192.05M
10.83%-940.84M
103.55%43.77M
89.69%-109.36M
24.84%-303.44M
Special items of earning before tax
-12.95%-63.46M
-55.61%13.14M
576.18%48.94M
24.10%29.08M
-249.57%-56.18M
24.14%29.6M
104.81%7.24M
-85.00%23.44M
-73.48%37.56M
-70.63%23.84M
Earning before tax
-42.61%5.68B
-27.05%3.89B
-10.57%13.76B
16.21%12.69B
14.46%9.9B
11.22%5.33B
9.85%15.39B
3.09%10.92B
7.69%8.65B
18.22%4.79B
Tax
19.60%-980.52M
21.02%-743.95M
4.14%-2.36B
-10.81%-2.19B
5.60%-1.22B
5.76%-941.91M
-2.31%-2.46B
4.18%-1.97B
10.28%-1.29B
1.63%-999.49M
After-tax profit from continuing operations
-45.84%4.7B
-28.34%3.14B
-11.80%11.41B
17.40%10.5B
17.98%8.68B
15.69%4.39B
11.41%12.93B
4.85%8.94B
11.62%7.36B
24.87%3.79B
Earning after tax
-45.84%4.7B
-28.34%3.14B
-11.80%11.41B
17.40%10.5B
17.98%8.68B
15.69%4.39B
11.41%12.93B
4.85%8.94B
11.62%7.36B
24.87%3.79B
Minority profit
-62.30%550.89M
-54.16%466.2M
3.02%2.74B
3.74%2.32B
-1.50%1.46B
-8.58%1.02B
-17.84%2.66B
-7.07%2.23B
-10.27%1.48B
23.46%1.11B
Profit attributable to shareholders
-42.50%4.15B
-20.56%2.68B
-15.63%8.67B
21.94%8.18B
22.90%7.22B
25.77%3.37B
22.70%10.28B
9.52%6.71B
18.95%5.87B
25.46%2.68B
Basic earnings per share
-57.69%0.11
-20.00%0.12
-26.67%0.33
10.71%0.31
8.33%0.26
25.00%0.15
28.57%0.45
7.69%0.28
14.29%0.24
20.00%0.12
Diluted earnings per share
-57.69%0.11
-20.00%0.12
-26.67%0.33
10.71%0.31
8.33%0.26
25.00%0.15
28.57%0.45
7.69%0.28
14.29%0.24
0.12
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Turnover -10.65%298.84B3.81%149.95B6.95%633.87B17.70%467.32B15.65%334.46B22.39%144.45B18.40%592.67B13.61%397.04B15.22%289.2B25.00%118.03B
Operating income -10.65%298.84B3.81%149.95B6.95%633.87B17.70%467.32B15.65%334.46B22.39%144.45B18.40%592.67B13.61%397.04B15.22%289.2B25.00%118.03B
Operating expenses 10.44%-271.8B-5.25%-137.67B-6.90%-572.46B-18.21%-424.22B-15.74%-303.47B-23.84%-130.81B-19.69%-535.52B-14.04%-358.87B-15.73%-262.19B-26.32%-105.63B
Gross profit -12.74%27.04B-10.04%12.27B7.46%61.41B12.92%43.11B14.72%30.99B10.05%13.64B7.56%57.15B9.66%38.18B10.49%27.01B14.78%12.4B
Selling expenses 0.43%-1.39B-6.35%-699.61M-9.93%-3.17B-14.71%-2.01B-13.42%-1.39B-10.80%-657.85M-5.12%-2.88B-0.16%-1.76B-6.19%-1.23B-8.42%-593.74M
Administrative expenses -5.21%-5.71B-3.76%-3.19B-9.64%-12.36B-10.94%-8.08B-9.83%-5.43B-10.56%-3.07B-3.22%-11.27B-0.40%-7.29B2.02%-4.94B-1.64%-2.78B
Research and development expenses 11.25%-8.07B-0.11%-2.82B-5.33%-19.73B-15.76%-13.54B-18.99%-9.09B-7.14%-2.81B-17.81%-18.73B-17.88%-11.69B-27.13%-7.64B-54.55%-2.63B
Profit from asset sales 2,395.55%847.46M832.47%147.71M118.58%663.08M-77.69%51.26M-67.28%33.96M117.27%15.84M-55.99%303.36M-47.48%229.74M-75.74%103.78M-10.24%7.29M
Revaluation surplus 34.04%-216.6M-5,553.63%-183.86M1.12%-314.22M-10.35%-458.64M-151.26%-328.38M-140.28%-3.25M-278.59%-317.78M-604.71%-415.61M-353.88%-130.7M-25.85%8.07M
-Changes in the fair value of other assets 34.04%-216.6M-5,553.63%-183.86M1.12%-314.22M-10.35%-458.64M-151.26%-328.38M-140.28%-3.25M-278.59%-317.78M-604.71%-415.61M-353.88%-130.7M-25.85%8.07M
Impairment and provision -57.88%-4.87B-0.46%-915.76M-80.37%-8.95B-0.78%-4.01B-5.58%-3.08B-7.47%-911.58M7.07%-4.96B-25.11%-3.98B-38.32%-2.92B-22.29%-848.22M
-Other impairment is provision -57.88%-4.87B-0.46%-915.76M-80.37%-8.95B-0.78%-4.01B-5.58%-3.08B-7.47%-911.58M7.07%-4.96B-25.11%-3.98B-38.32%-2.92B-22.29%-848.22M
Special items of operating profit 30.58%-351.75M37.38%-150.35M14.93%-927.25M44.19%-512.87M19.45%-506.66M-85.71%-240.12M20.17%-1.09B-673.91%-919.01M-18.17%-628.99M-38.01%-129.3M
Operating profit -37.45%6.38B-25.39%4.1B-9.93%14.7B21.42%13.17B17.01%10.2B8.29%5.49B7.28%16.33B-7.00%10.85B-2.56%8.72B15.90%5.07B
Financing cost -156.36%-637.3M-16.02%-222.82M-5.13%-989.12M-1,280.18%-516.54M-127.33%-248.6M36.71%-192.05M10.83%-940.84M103.55%43.77M89.69%-109.36M24.84%-303.44M
Special items of earning before tax -12.95%-63.46M-55.61%13.14M576.18%48.94M24.10%29.08M-249.57%-56.18M24.14%29.6M104.81%7.24M-85.00%23.44M-73.48%37.56M-70.63%23.84M
Earning before tax -42.61%5.68B-27.05%3.89B-10.57%13.76B16.21%12.69B14.46%9.9B11.22%5.33B9.85%15.39B3.09%10.92B7.69%8.65B18.22%4.79B
Tax 19.60%-980.52M21.02%-743.95M4.14%-2.36B-10.81%-2.19B5.60%-1.22B5.76%-941.91M-2.31%-2.46B4.18%-1.97B10.28%-1.29B1.63%-999.49M
After-tax profit from continuing operations -45.84%4.7B-28.34%3.14B-11.80%11.41B17.40%10.5B17.98%8.68B15.69%4.39B11.41%12.93B4.85%8.94B11.62%7.36B24.87%3.79B
Earning after tax -45.84%4.7B-28.34%3.14B-11.80%11.41B17.40%10.5B17.98%8.68B15.69%4.39B11.41%12.93B4.85%8.94B11.62%7.36B24.87%3.79B
Minority profit -62.30%550.89M-54.16%466.2M3.02%2.74B3.74%2.32B-1.50%1.46B-8.58%1.02B-17.84%2.66B-7.07%2.23B-10.27%1.48B23.46%1.11B
Profit attributable to shareholders -42.50%4.15B-20.56%2.68B-15.63%8.67B21.94%8.18B22.90%7.22B25.77%3.37B22.70%10.28B9.52%6.71B18.95%5.87B25.46%2.68B
Basic earnings per share -57.69%0.11-20.00%0.12-26.67%0.3310.71%0.318.33%0.2625.00%0.1528.57%0.457.69%0.2814.29%0.2420.00%0.12
Diluted earnings per share -57.69%0.11-20.00%0.12-26.67%0.3310.71%0.318.33%0.2625.00%0.1528.57%0.457.69%0.2814.29%0.240.12
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg